Clinical trial
Anticholinergic Burden as a Modifiable Risk Factor in Cardiac Surgery: Evidence From a Randomized Controlled Study
NCT06349057 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Anticholinergic Burden as a Modifiable Risk Factor in Cardiac Surgery: Evidence From a Randomized Controlled Study
- Lead sponsor
- Ankara City Hospital Bilkent
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- January 1, 2024
- Completion date
- December 30, 2025
- Enrollment
- 120 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
length of hospital stay, postoperative complications, postoperative recovery